Portland, Oregon
Alzheimer's disease clinical trials in Portland, OR
9 Alzheimer's disease studies are recruiting participants at sites in Portland as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Portland at a glance
- 9 studies are recruiting at a site in Portland.
- By phase: Phase 1 (1), Phase 2 (3), Phase 2/3 (1), Phase 3 (3), Observational (1).
- By sponsor: industry (7), university, hospital or other (2).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Portland
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Summit Research Network Inc.
- Registry record
- NCT07177352 · updated
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
- Phase 2/3
- Ages 55 to 90
- All sexes
- Sponsor
- Exciva GmbH
- Study site
- Oregon Health & Science University
- Registry record
- NCT07284472 · updated
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Sanofi
- Study site
- Summit Research Network - Portland - Northwest Vaughn Street- Site Number : 8400002
- Registry record
- NCT07688213 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Oregon Health and Science University · Summit Headlands
- Registry record
- NCT07589595 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Summit Headlands
- Registry record
- NCT06976216 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Study site
- Summitt Research
- Registry record
- NCT06847321 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study site
- Oregon Health & Science University
- Registry record
- NCT06563895 · updated
OCT Angiography and NRAI in Dementia
- Observational
- Ages 55 and older
- All sexes
- Sponsor
- Oregon Health and Science University
- Study site
- Oregon Health & Science University
- Registry record
- NCT03761381 · updated
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
- Phase 1
- Ages 60 to 85
- All sexes
- Sponsor
- Oregon Health and Science University
- Study site
- Oregon Health & Science University
- Registry record
- NCT05591027 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Portland, OR on ClinicalTrials.gov.
Ask about studies near Portland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections